JP Morgan Chase
ACH

JP Morgan Chase’s Accendra Health ACH Stock Holding History

JP Morgan Chase’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-135,000
Closed -$2.64M – 7089
2022
Q4 		$2.64M Buy
+135,000
New +$2.63M ﹤0.01% 3348
2021
Q4 		– Sell
-127,500
Closed -$3.99M – 6870
2021
Q3 		$3.99M Buy
+127,500
New +$5.02M ﹤0.01% 3224

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
KCM
Kennondale Capital Management Richmond, Virginia $150M AUM 46.45% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

JP Morgan Chase's ACH Position: Q2 2026 in Review

JP Morgan Chase increased its Accendra Health (ACH) stake by 3.6% in Q2 2026, buying an estimated $3.31K and bringing the position to 30,689 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #5991.

JP Morgan Chase first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.7M in Q1 2017. 70 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • JP Morgan Chase held 30,689 shares of Accendra Health worth $106K as of Q2 2026.
  • JP Morgan Chase bought 1,064 Accendra Health shares in Q2 2026, an estimated $3.31K.
  • Accendra Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5991 holding.
  • JP Morgan Chase first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Accendra Health position peaked at $55.7M in Q1 2017.
  • 70 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.